Soru

Zorluk: OrtaInfectious Diseases

Match each clinical presentation of infective endocarditis with the most appropriate empiric or targeted antimicrobial regimen.

  • A 55-year-old man with native valve endocarditis caused by methicillin-susceptible Staphylococcus aureus (MSSA) and no known drug allergies.Intravenous cefazolin or intravenous nafcillin
  • A 68-year-old woman with suspected prosthetic valve endocarditis, presenting with fever and a new murmur 3 months after a surgical aortic valve replacement.Intravenous vancomycin, intravenous gentamicin, and oral rifampin
  • A 72-year-old man with native valve endocarditis caused by Enterococcus faecalis and a history of severe chronic kidney disease.Intravenous ampicillin plus intravenous ceftriaxone
  • A 45-year-old woman with subacute native valve endocarditis caused by Streptococcus gallolyticus that is highly susceptible to penicillin.Intravenous aqueous crystalline penicillin G or intravenous ceftriaxone (monotherapy)

Cevap

The correct matches are: Native valve MSSA endocarditis pairs with IV cefazolin or nafcillin; early prosthetic valve endocarditis pairs with IV vancomycin, gentamicin, and rifampin; Enterococcal endocarditis in a patient with chronic kidney disease pairs with IV ampicillin plus ceftriaxone; and highly penicillin-susceptible Streptococcus gallolyticus endocarditis pairs with IV penicillin G or ceftriaxone monotherapy.
Each pathogen and clinical scenario in infective endocarditis requires a specific, guideline-directed antimicrobial regimen to ensure bactericidal activity, penetrate biofilms on prostheses, and minimize systemic toxicity.

Adım Adım Çözüm

1
Analyze the antimicrobial requirement for MSSA native valve endocarditis.
Identify that beta-lactam therapy (nafcillin, oxacillin, or cefazolin) is superior to vancomycin.
Beta-lactams provide faster bacteremia clearance and better clinical outcomes for MSSA infections.
2
Evaluate the patient with suspected early prosthetic valve endocarditis (PVE).
Select a broad-spectrum, three-drug regimen: vancomycin, gentamicin, and rifampin.
Early PVE is frequently caused by coagulase-negative staphylococci; vancomycin provides MRSA/MRSE coverage, rifampin penetrates biofilms, and gentamicin provides early synergy.
3
Assess the treatment for Enterococcus faecalis endocarditis in a patient with severe chronic kidney disease.
Select ampicillin combined with ceftriaxone.
Enterococci require synergistic therapy for bactericidal activity. Ampicillin plus ceftriaxone avoids the nephrotoxicity associated with the alternative ampicillin plus gentamicin regimen.
4
Review the optimal therapy for highly penicillin-susceptible Streptococcus gallolyticus endocarditis.
Select monotherapy with penicillin G or ceftriaxone.
Monotherapy is highly effective for exquisitely susceptible streptococci and avoids unnecessary exposure to broader-spectrum agents or aminoglycosides.

Anahtar Kavram

Appropriate antimicrobial selection for infective endocarditis depends heavily on the causative pathogen, the presence of prosthetic material (requiring biofilm penetration), and patient-specific comorbidities such as underlying renal dysfunction.
Bu soruyu puanla